Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
NU
NuSkin Enterprises, Inc.
NUS
Mkt Cap
$250.7M
Volume
410.64K
Next Earnings
November 5th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
NU
NUS
NU
NuSkin Enterprises, Inc.
NUS
News
·
Global Derma Roller Market Size To Worth USD 668.17 Million By 2033 | CAGR OF 8.22%
Mkt Cap
$253.6M
Volume
410.64K
Next Earnings
November 5th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
Global Derma Roller Market Size To Worth USD 668.17 Million By 2033 | CAGR OF 8.22%
The global derma roller market is expected to grow from $303.14 million in 2023 to $668.17 million by 2033, driven by increasing demand for non-invasive cosmetic procedures and growing interest in skincare products.
GlobeNewswire Inc. · Sep 9, 2024
Why Nu Skin Enterprises Stock Flopped on Friday
Nu Skin Enterprises (NUS) shares fell over 3% after the company reported a 12% year-over-year decline in Q2 revenue and a steep drop in non-GAAP net income, despite beating analyst estimates. The company provided guidance for Q3 and full-year 2024, but the earnings forecast fell short of expectations.
The Motley Fool · Aug 9, 2024
Nu Skin (NUS) Troubled by Customer Acquisition Challenges
Nu Skin (NUS) has been battling persistent macroeconomic headwinds across most regions, which has affected customer and affiliate acquisition.
Zacks Investment Research · Jun 20, 2024
Nu Skin (NUS) Up 5.6% Since Last Earnings Report: Can It Continue?
Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Investment Research · Jun 7, 2024
Nu Skin (NUS) Q1 Earnings Beat, Revenues Hurt by Currency Woes
Nu Skin's (NUS) first-quarter 2024 results reflect challenges related to volatile currency movements, while cost-management efforts work well.
Zacks Investment Research · May 9, 2024
Nu Skin Enterprises (NUS) Surpasses Q1 Earnings Estimates
Nu Skin (NUS) delivered earnings and revenue surprises of 80% and 3.09%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Research · May 8, 2024
Nu Skin (NUS) Q1 Earnings Coming Up: Factors to Consider
Nu Skin's (NUS) first-quarter 2024 earnings will likely reflect the adverse impact of macroeconomic challenges like a slowdown in consumer spending. Unfavorable currency translations are a concern.
Zacks Investment Research · May 7, 2024
Is Invesco High Yield Equity Dividend Achievers ETF (PEY) a Strong ETF Right Now?
Smart Beta ETF report for PEY
Zacks Investment Research · Mar 29, 2024
Why Is Inter Parfums (IPAR) Down 4.1% Since Last Earnings Report?
Inter Parfums (IPAR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Investment Research · Mar 28, 2024
Nu Skin (NUS) Down 7.2% Since Last Earnings Report: Can It Rebound?
Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Investment Research · Mar 15, 2024
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
NU
NUS
NuSkin Enterprises, Inc.
Buy
Sell
Market
Limit
Soon
NUS
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any NUS yet.
Related Tickers
CO
COTY
—
Earnings
Dividends
Last · Aug 28
Quarterly
Amount
$0.0600
Yield
4.67%
Annual
$0.24